Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

Clinical trial NCT02425111 · COMPLETED

Trial details

NCT number: NCT02425111
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2015-03-30
Primary completion: 2017-06-02
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.